$10.490
-0.235 (-2.24%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Design Therapeutics Inc (DSGN) Moving Averages Convergence Divergence (MACD) indicator is -0.73, suggesting DSGN is Strong sell.
Design Therapeutics Inc (DSGN) 20-Day simple moving average is 11.38, while Design Therapeutics Inc (DSGN) share price is $—, making it Sell.
Design Therapeutics Inc (DSGN) 60-Day simple moving average is 13.26, while Design Therapeutics Inc (DSGN) share price is $—, making it Sell.
Technical Analysis for DSGN
AI Technical DSGNAs of 2026-10-17, the technical board for Design Therapeutics Inc (DSGN) reads strong sell: 0 indicators are flashing buy, 9 are indicating sell, and 4 are neutral. Price at $10.49 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 37.63, MACD stands at -0.729 (Sell), Stochastic %K stands at 38.222, Stochastic %D stands at 37.3 and CCI stands at -69.553.
DSGN trades below the 60-day SMA (13.26) and below the 200-day SMA (12.13). Immediate resistance sits at Classic R1 11.84, then R2 13.10. Support sits at Classic S1 9.40, then S2 8.21.
Design Therapeutics Inc (DSGN) Support & Resistance Level
Design Therapeutics Inc (DSGN) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 37.630 |
| STOCHk_14_3_3 | 38.222 |
| STOCHd_14_3_3 | 37.300 |
| CCI_20 | -69.553 |
| AO_5_34 | -1.584 |
| MOM_10 | -1.000 |
| MACD_12_26_9 | -0.729 |
Design Therapeutics Inc (DSGN) Relative Strength Index (RSI_14) is 37.630, creating a Neutral signal.
Design Therapeutics Inc (DSGN) Stochastic %K is 38.222, creating a Neutral signal.
Design Therapeutics Inc (DSGN) Stochastic %D is 37.300, creating a Neutral signal.
Design Therapeutics Inc (DSGN) CCI_20 is -69.553, creating a Neutral signal.
Design Therapeutics Inc (DSGN) Awesome Oscillator (AO) is -1.584, creating a Sell signal.
Design Therapeutics Inc (DSGN) Momentum (MOM) is -1.000, creating a Sell signal.
Design Therapeutics Inc (DSGN) Moving Average Convergence Divergence (MACD) is -0.729, creating a Sell signal.
Design Therapeutics Inc (DSGN) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 10.654 | Sell |
| MA_10 | 10.582 | Sell |
| MA_20 | 11.382 | Sell |
| MA_60 | 13.258 | Sell |
| MA_200 | 12.130 | Sell |
| MA_250 | 11.387 | Sell |
Design Therapeutics Inc (DSGN) 5-Day simple moving average is 10.654, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 10-Day simple moving average is 10.582, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 20-Day simple moving average is 11.382, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 60-Day simple moving average is 13.258, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 200-Day simple moving average is 12.130, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
Design Therapeutics Inc (DSGN) 250-Day simple moving average is 11.387, while Design Therapeutics Inc (DSGN) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.